Cytokinetics, Incorporated (CYTK)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 64.02 |
| Open | 63.63 |
| Bid | 61.98 x 100 |
| Ask | 62.12 x 100 |
| Day's range | 61.25 - 64.61 |
| 52-week range | 25.98 - 110.25 |
| Volume | |
| Avg. volume | 1,926,919 |
| Market cap | 6.696B |
| Beta (5Y monthly) | 0.72 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -5.40 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 93.59 |
GuruFocus.comCytokinetics Inc (CYTK) Reports Q1 2024 Earnings: Widening Losses Amid Expansive Clinical Trials
Deep Dive into Financials and Strategic Developments
Simply Wall St.Cytokinetics First Quarter 2024 Earnings: Misses Expectations
Cytokinetics ( NASDAQ:CYTK ) First Quarter 2024 Results Key Financial Results Net loss: US$135.6m (loss widened by 3.3...
Insider MonkeyCytokinetics, Incorporated (NASDAQ:CYTK) Q1 2024 Earnings Call Transcript
Cytokinetics, Incorporated (NASDAQ:CYTK) Q1 2024 Earnings Call Transcript May 9, 2024 Cytokinetics, Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. And welcome ladies and gentlemen to Cytokinetics First Quarter 2024 Conference Call. [Operator Instructions] I will now […]
© 2024 Yahoo. All rights reserved.